文献速递白血病

国际室间研究评估微滴数字PCR检测慢性髓性白血病BCR-ABL1

Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
PubMed 文献 · Br J Haematol · 2021-06-10

与RTqPCR相比,检出限相似但室间变异更小、线性更优。

核心结论

  • RTddPCR检测BCR-ABL1可检出深分子学反应,线性更好且室间变异小于RTqPCR,有助于改善患者管理并支持无治疗缓解相关临床试验。

主要发现

  • 11家同时进行两种检测的实验室中,RTddPCR检出限与RTqPCR相似,但室间变异更小、线性更好。

临床怎么用

  • RTddPCR可用于监测慢性髓性白血病深分子学反应,尤其适用于以无治疗缓解为目标的临床场景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measurement of BCR activator of RhoGEF and GTPase -ABL proto-oncogene 1, non-receptor tyrosine kinase (BCR-ABL1) mRNA levels by reverse transcription quantitative polymerase chain reaction (RTqPCR) has been critical to treatment protocols and clinical trials in chronic myeloid leukaemia; however, interlaboratory variation remains a significant issue. Reverse transcriptase droplet digital PCR (RTddPCR) has shown potential to improve testing but a large-scale interlaboratory study is required to definitively establish this. In the present study, 10 BCR-ABL1-positive samples with levels ranging from molecular response (MR)1·0 -MR5·0 were tested by 23 laboratories using RTddPCR with the QXDX BCR-ABL %IS kit. A subset of participants tested the samples using RTqPCR. All 23 participants using RTddPCR detected BCR-ABL1 in all samples to MR4·0 . Detection rates for deep-response samples were 95·7% at MR4·5 , 78·3% at MR4·7 and 87·0% at MR5·0 . Interlaboratory coefficient of variation was indirectly proportional to BCR-ABL1 level ranging from 29·3% to 69·0%. Linearity ranged from 0·9330 to 1·000 (average 0·9936). When results were compared for the 11 participants who performed both RTddPCR and RTqPCR, RTddPCR showed a similar limit of detection to RTqPCR with reduced interlaboratory variation and better assay linearity. The ability to detect deep responses with RTddPCR, matched with an improved linearity and reduced interlaboratory variation will allow improved patient management, and is of particular importance for future clinical trials focussed on achieving and maintaining treatment-free remission.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Scott S, Cartwright A, Francis S, et al. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study. Br J Haematol. 2021. PMID: 34114218. doi:10.1111/bjh.17521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。